Biomedical Engineering Reference
In-Depth Information
9. Lai Y, Gallo RL (2009) AMPed up immunity: how antimicrobial peptides have multiple roles
in immune defense. Trends Immunol 30(3):131-141
10. Matsuzaki K (2009) Control of cell selectivity of antimicrobial peptides. Biochim Biophys
Acta 1788(8):1687-1692
11. Jenssen H, Hamill P, Hancock RE (2006) Peptide antimicrobial agents. Clin Microbiol Rev 19
(3):491-511
12. Overhage J, Campisano A, Bains M, Torfs EC, Rehm BH, Hancock RE (2008) Human host
defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun 76(9):4176-4182
13. Scott MG, Gold MR, Hancock RE (1999) Interaction of cationic peptides with lipoteichoic
acid and gram-positive bacteria. Infect Immun 67(12):6445-6453
14. Kiran MD, Adikesavan NV, Cirioni O, Giacometti A, Silvestri C, Scalise G, Ghiselli R, Saba V,
Orlando F, Shoham M, Balaban N (2008) Discovery of a quorum-sensing inhibitor of drug-
resistant staphylococcal infections by structure-based virtual screening. Mol Pharmacol 73
(5):1578-1586
15. Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Nat Rev 3(3):238-250
16. Melo MN, Ferre R, Castanho MA (2009) Antimicrobial peptides: linking partition, activity and
high membrane-bound concentrations. Nat Rev 7(3):245-250
17. Park CB, Yi KS, Matsuzaki K, Kim MS, Kim SC (2000) Structure-activity analysis of buforin
II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-
penetrating ability of buforin II. Proc Natl Acad Sci U S A 97(15):8245-8250
18. Wang G (2008) Structures of human host defense cathelicidin LL-37 and its smallest anti-
microbial peptide KR-12 in lipid micelles. J Biol Chem 283(47):32637-32643
19. De Smet K, Contreras R (2005) Human antimicrobial peptides: defensins, cathelicidins and
histatins. Biotechnol Lett 27(18):1337-1347
20. Gennaro R, Zanetti M (2000) Structural features and biological activities of the cathelicidin-
derived antimicrobial peptides. Biopolymers 55(1):31-49
21. Cirioni O, Giacometti A, Silvestri C, Della Vittoria A, Licci A, Riva A, Scalise G (2006) In
vitro activities of tritrpticin alone and in combination with other antimicrobial agents against
Pseudomonas aeruginosa
. Antimicrob Agents Chemother 50(11):3923-3925
22. Yeaman MR, Yount NY (2003) Mechanisms of antimicrobial peptide action and resistance.
Pharmacol Rev 55(1):27-55. doi:
10.1124/pr.55.1.2
23. Qian S, Heller WT (2011) Peptide-induced asymmetric distribution of charged lipids in a vesicle
bilayer revealed by small-angle neutron scattering. J Phys Chem B 115(32):9831-9837.
doi:
10.1021/jp204045t
24. Lupetti A, Welling M, Pauwels E, Nibbering P (2003) Radiolabelled antimicrobial peptides for
infection detection. Lancet Infect Dis 3:223-229
25. Welling M, Paulusma-Annema A, Balter H, Pauwels E, Nibbering P (2000) Technetium-99m
labelled antimicrobial peptides discriminate between bacterial
infections and sterile
inflammations. Eur J Nucl Med 27:292-301
26. Sarda-Mantel L, Saleh-Mghir A, Welling MM, Meulemans A, Vrigneaud JM, Raguin O,
Hervatin F, Martet G, Chau F, Lebtahi R, Le Guludec D (2007) Evaluation of
99m
Tc-UBI
29-41 scintigraphy for specific detection of experimental
Staphylococcus aureus
prosthetic
joint infections. Eur J Nucl Med Mol Imaging 34(8):1302-1309. doi:
10.1007/s00259-007-
27. Mel´ndez-Alafort L, Rodr´guez-Cort´s J, Ferro-Flores G, Arteaga De Murphy C, Herrera-
Rodr´guez R, Mitsoura E, Mart´nez-Duncker C (2004) Biokinetics of
99m
Tc-UBI 29-41 in
humans. Nucl Med Biol 31(3):373-379. doi:
10.1016/j.nucmedbio.2003.10.005
28. Akhtar M, Qaisar A, Irfanullah J, Iqbal J, Khan B, Jehangir M, Nadeem M, Khan M, Afzal M,
ul-Haq I, Imran M (2005) Antimicrobial peptide
99m
Tc-ubiquicidin 29-41 as human infection-
imaging agent: clinical trial. J Nucl Med 46:567-573
29. Mel´ndez-Alafort L, Nadali A, Pasut G, Zangoni E, De Caro R, Cariolato L, Giron MC,
Castagliuolo I, Veronese FM, Mazzi U (2009) Detection of sites of infection in mice using
Search WWH ::
Custom Search